Epidemiology of permanent contraception
ESC Congress Library. Lobo Abascal P. Jun 22, 2012; 21582 Disclosure(s): MSD Bayer TEVA HRA Pharma Effick
Dr. Paloma Lobo Abascal
Dr. Paloma  Lobo Abascal
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Learning Objectives
Rate & Comment (0)
know the prevalence of permanent contraception in our area.

Compare the data with those from other countries in the world

Understand the reasons for the declining of the use of the method in Europe

    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings